Cooler News: How to Effectively Scale COVID-19 Vaccine Storage Solutions

 

As the first COVID vaccine to be given FDS emergency authorization begins its distribution, many healthcare organizations have been tasked with a new challenge; figuring out how to store the vaccine at ultra-cold temperatures. How can healthcare organizations set themselves up for success quickly?

In this episode of Cooler News, host Daniel Litwin is joined by Maureen Holm, Solution Sales Manager at KPS Global, to discuss how the company’s freezer and refrigerator solutions can help healthcare providers scale their vaccine distribution efforts.

Although three separate vaccines have been created to help curb the effects of the coronavirus pandemic, the unique temperature storage needs for the Pfizer, Moderna and AstraZeneca vaccines have brought about this unique cold-storage issue.

Not only are the freezer units needed to store these vaccines expensive to procure, but the current units on the market are smaller than what is needed to store the large amounts of the vaccines needed to get them to the community. Although healthcare organizations have the cold temperature capabilities for proper vaccine storage, the scale of storage needed is the main issue.

Additionally, healthcare organizations are struggling to find centralized locations for these freezer units so that the vaccines can be accessible to the general public, Holm said.

At the manufacturing level, companies could “expand their freezers and refrigerators into larger walk-in areas as opposed to smaller reachable spaces,” Holm said. This would also allow healthcare providers to keep a large number of vaccines on hand for the public.

KPS Global’s modular freezer solutions can help with this, thanks to their unique design.

“We use an interlocking system so that each panel can be deployed at a certain size,” Holm said.

Each unit can be customized for the amount of space available, while its interlocking panels make it easy to put together and install.

With these new breakthroughs, KPS Global hopes that their solutions will help impact the fight against COVID-19 “in a very positive way.”

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More